Articles mentioning Bristol-Myers Squibb (BMY)

Results 11 - 20 of 844 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for BMY

Investing | June 24, 2016

Why Investors Are Paying a Premium for These 3 Drugmakers

Despite a cloud over the industry, these three are still very expensive. Here's why.

Investing | June 21, 2016

3 Ways This $30 Billion Market Is Bristol's for the Taking

How this "Big Pharma" is revolutionizing the fight against cancer and well-positioned for long-term growth.

Investing | June 10, 2016

3 Cutting-Edge Healthcare Stocks Millennials Should Seriously Consider Buying

The cutting edge of a healthcare trend is often a very profitable place to be.

Investing | May 26, 2016

Cancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases

Big Pharma is out with encouraging cancer-survival data and response rates prior to the June ASCO event.

Investing | May 12, 2016

Exelixis, Inc. Prepares for Blastoff

The biotech launches Cabometyx for kidney cancer.

Investing | May 10, 2016

1 Wonder Drug Sends Bristol-Myers Squibb Co. Rocketing 13% Higher in April

Bristol-Myers' shares touched a 17-year high in April -- can the good times continue?

Investing | May 05, 2016

7 Figures That Sum Up Merck & Co.'s First Quarter

First quarter earnings could impact trading in this big cap pharmaceutical stock. Here's what you need to know.

Investing | April 26, 2016

3 Stocks Any Investor Can Buy

Nike, Microsoft, and Bristol-Myers Squibb could be worth owning in any investor's portfolio.

Investing | April 26, 2016

Exelixis, Inc.'s Cabometyx Approved: Let the Kidney Cancer Battle Begin!

Former partners are set to battle it out in the marketplace.

Investing | April 21, 2016

3 Dividend Stocks for Retirees

Here are a few good reasons why ExxonMobil, Bristol-Myers Squibb, and Microsoft would make smart additions to conservative income hunters' portfolios.

Results 11 - 20 of 844 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for BMY